Your session is about to expire
← Back to Search
Iron Supplement
Iron Supplement to Improve Iron Status Following Bariatric Surgery
N/A
Waitlist Available
Research Sponsored by Purdue University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing two types of iron pills to see which one works better for people who had weight-loss surgery and are low on iron. The goal is to find out which pill increases iron levels and improves health more effectively.
Eligible Conditions
- Iron-Deficiency Anemia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Iron status
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: AspironTM 65 mg t.i.d.Experimental Treatment1 Intervention
AspironTM, an organic formulation of iron, is the experimental treatment for oral supplementation of iron deficiency
Group II: Ferrous sulfateActive Control1 Intervention
Ferrous sulfate 65 mg. t.i.d is the standard of care for oral supplementation for iron deficiency
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Oral iron supplementation
2014
N/A
~70
Find a Location
Who is running the clinical trial?
Purdue UniversityLead Sponsor
233 Previous Clinical Trials
71,309 Total Patients Enrolled
Indiana UniversityLead Sponsor
1,040 Previous Clinical Trials
1,220,000 Total Patients Enrolled